FGC
LGND icon

Financial Gravity Companies’s Ligand Pharmaceuticals LGND Stock Holding History

Financial Gravity Companies’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$1K Buy
+16
New +$1.71K ﹤0.01% 1135
2018
Q1 		$1K Sell
11
-920
-99% -$91K ﹤0.01% 1185
2017
Q4 		$92K Buy
+931
New +$80.7K 0.11% 190

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Financial Gravity Companies's LGND Position: Q4 2018 in Review

Financial Gravity Companies opened a new position in Ligand Pharmaceuticals (LGND) in Q4 2018: 16 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #1135 among its holdings. This is a return to the name: Financial Gravity Companies previously reported a position in LGND as recently as Q1 2018.

Financial Gravity Companies first reported a position in LGND in Q4 2017 and has held it in 3 quarters since. The position peaked at $92K in Q4 2017. 362 funds tracked by Wall St. Rank hold LGND as of Q4 2018.

  • Financial Gravity Companies held 16 shares of Ligand Pharmaceuticals worth $1K as of Q4 2018.
  • Ligand Pharmaceuticals was a new Financial Gravity Companies position in Q4 2018.
  • Ligand Pharmaceuticals made up ﹤0.01% of Financial Gravity Companies's portfolio in Q4 2018, its #1135 holding.
  • Financial Gravity Companies first reported a position in Ligand Pharmaceuticals in Q4 2017 and has held it in 3 quarters since.
  • Financial Gravity Companies's Ligand Pharmaceuticals position peaked at $92K in Q4 2017.
  • 362 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2018.

Based on Financial Gravity Companies's 13F filing for Q4 2018, filed 4 Feb 2019.